ABIGAIL HILL: Open Payments
NPI 1881344042 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 30 payments from 11 companies in 2025. Trend: 2023 $658 · 2024 $883 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $186 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $94 |
| Novartis Pharmaceuticals Corporation | 5 | $82 |
| Novo Nordisk Inc | 3 | $60 |
| LANTHEUS MEDICAL IMAGING, INC. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Amgen Inc. | 2 | $28 |
| Octapharma USA, Inc. | 1 | $16 |
Products named: WATCHMAN FLX, JARDIANCE, LEQVIO, Wegovy, DEFINITY, Kerendia, AMVUTTRA, REPATHA.
Industry payments across MO — which companies pay providers there.
